Triamcinolone hexacetonide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triamcinolone hexacetonide and what is the scope of patent protection?
Triamcinolone hexacetonide
is the generic ingredient in one branded drug marketed by Ethypharm and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for triamcinolone hexacetonide
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Clinical Trials: | 22 |
| DailyMed Link: | triamcinolone hexacetonide at DailyMed |
Recent Clinical Trials for triamcinolone hexacetonide
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Nigde Omer Halisdemir University | PHASE4 |
| Kastamonu University | PHASE4 |
| Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for triamcinolone hexacetonide
US Patents and Regulatory Information for triamcinolone hexacetonide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ethypharm | ARISTOSPAN | triamcinolone hexacetonide | INJECTABLE;INJECTION | 016466-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ethypharm | ARISTOSPAN | triamcinolone hexacetonide | INJECTABLE;INJECTION | 016466-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
